Friday, August 5, 2022

5 Questions With... David Lovinger, Ph.D.—NIAAA Spectrum Article

Having trouble viewing this email? View it as a web page. | Received this in error? Manage your subscriptions here.

NIAAA Spectrum Logo

Volume 14, Issue 2  Spring 2022


5 QUESTIONS WITH... David Lovinger, Ph.D., Acting Scientific Director, Division of Intramural Clinical and Biological Research, and Chief of the Laboratory for Integrative Neuroscience, NIAAA

In this interview with Dr. David Lovinger, learn about his work at NIAAA, how he chose to work in the field of neurobiological research as it relates to alcohol-related behaviors, his collaboration with research colleagues during the COVID-19 pandemic, and the importance of mentoring young scientists.

Read more...

 


This email was sent to edwardlorilla1986.paxforex@blogger.com on behalf of The National Institute on Alcohol Abuse and Alcoholism · 6700B Rockledge Drive · Bethesda, MD 20892 · 301-443-3860 GovDelivery logo

No comments:

Post a Comment

Most important medical advance in 100 years

Artificial Intelligence is being harnessed to create breakthrough drugs no one has ever seen before. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ...